SCHEMBL6153699

SCHEMBL6153699

NC(=O)c1ccc(NC(=O)c2cccc(N)c2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 4/20 0.67
BCAT2 O15382 1/20 0.60
KMT2A Q03164 4/20 0.58
MEN1 O00255 3/20 0.58
PLAU P00749 3/20 0.57
F2 P00734 1/20 0.57
PLG P00747 1/20 0.57
KLKB1 P03952 1/20 0.57
PRSS1 P07477 1/20 0.57
LMNA P02545 1/20 0.56
POLB P06746 1/20 0.56
PKM P14618 1/20 0.56
APEX1 P27695 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
ULK1 O75385 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.55
NPSR1 Q6W5P4 1/20 0.55
HSD17B10 Q99714 1/20 0.55
NPC1 O15118 1/20 0.55
CASP3 P42574 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6153673 0.98 PTGS1 (0.65) PTGS1BCAT2KMT2AMEN1PLAU
SCHEMBL2127722 0.92 PTGS1 (0.77) PTGS1KMT2AMEN1LMNAPOLB
SCHEMBL17744815 0.89 KMT2A (0.73) PTGS1KMT2AMEN1LMNAPOLB
SCHEMBL31171945 0.88 PTGS1 (0.72) PTGS1KMT2AMEN1PLAULMNA
SCHEMBL309467 0.88 PTGS1 (0.72) PTGS1KMT2AMEN1PLAULMNA
SCHEMBL6866138 0.87 KMT2A (0.78) PTGS1KMT2AMEN1LMNAPOLB
SCHEMBL11593046 0.87 PTGS1 (0.75) PTGS1KMT2AMEN1LMNAPOLB
SCHEMBL11882113 0.86 PTGS1 (0.59) PTGS1KMT2AMEN1PLAUULK1
SCHEMBL7606386 0.86 KMT2A (0.70) PTGS1KMT2AMEN1LMNAPOLB
SCHEMBL21295922 0.85 PTGS1 (0.70) PTGS1KMT2AMEN1PLAUPRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3511709-B1 ACOUSTIC WAVE SENSORS AND METHODS OF SENSING A GAS-PHASE ANALYTE ROHM & HAAS ELECT MAT (US) 2023-11-01 EP disclosed
US-20050182040-A1 Benzamide derivatives DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-18 US disclosed
EP-1500643-A1 BENZAMIDE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182040-A1 Benzamide derivatives ROCK1, ROCK2, NHERF1 PTGS1 75/4885BCAT2 444/4885KMT2A 1307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.